Protective effect of nafamostat mesilate on injury of porcine hepatocytes by human plasma

Cell Transplantation

Volumn 8, Issue 4, 1999, Pages 419-425

  Kawazoe, Yasushi ^a   Eguchi, Susumu ^a   Sugiyama, Nozomu ^a   Yuzawa, Hiroyuki ^a   Kawashita, Yujo ^a   Fujioka, Hikaru ^a   Kanematsu, Takashi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Complement; Human plasma; Nafamostst mesilate; Porcine hepatocytes

Indexed keywords

ALBUMIN; COMPLEMENT COMPONENT C3; LACTATE DEHYDROGENASE; NAFAMSTAT MESILATE; PROTEINASE INHIBITOR; TRYPTASE;

ANIMAL CELL; ARTIFICIAL LIVER; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; COMPLEMENT BLOOD LEVEL; COMPLEMENT INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CICONIIFORMES; SUIDAE;

EID: 0032845938     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368979900800412     Document Type: Conference Paper

References (27)

1. Aoyama, T.; Ino, Y.; Oxeki, M.; Oda, M.; Sato, T.; Koshiyama, Y.; Suzuki, S.; Fujita, M. Pharmacological studies of FUT-175, nafamostat mesilate I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn. J. Pharmacol. 35:203-227; 1984.
2. Clavien, P. A.; Sanabria, J. R.; Upadhaya, A.; Harvey, P. R.; Strasberg, S. M. Evidence of the existence of a soluble mediator of cold preservation injury. Transplantation 56:44-53; 1993.
3. Fujii, S.; Hitomi, Y. New synthetic inhibitor of Clr. Cl esterase, thrombin, plasmin, kallikrein and trypsin. Biochem. Biophys. Acta 661:342-345; 1981.
4. Fujioka, H.; Cramer, D. V.; Yasunaga, C.; Tuso, P. J.; Wu, G. D.; Middleton, Y.; Moscioni, A. D.; Rozga, J.; Demetriou, A. A.; Makowka, L. Different patterns of reaction of human natural antibodies to pig hepatocytes and vascular endothelium. Liver Transplant. Surg. 1:85-93; 1995.
5. Gridelli, B.; Gatti, S.; Andreani, P.; Donato, M. F.; Bergamaschini, L.; Berti, H.; Di Mauro, P.; Maggioni, L.; Orsenigo, R.; Fassati, L. R.; Galmarini, D. Xenogeneic orthotopic liver transplantation from sheep to pig: Delay of rejection by FUT 175 infusion. Transplant. Proc. 28:784-787; 1996.
6. Ikari, N.; Sakai, Y.; Hitomi, Y.; Fujii, S. New synthetic inhibitor to the alternative complement pathway. Immunology 49:685-691; 1983.
7. Issekutz, A. C.; Roland, D. M.; Patrick, R. A. The effect of FUT-175 (nafamostat mesilate) on C3a, C4a, and C5a generation in vitro and inflammatory reactions in vivo. Int. J. Immunopharmacol. 12:1-9; 1990.
8. Kasai, S.; Sawa, M.; Mito, M. Is artificial liver clinically available? A historical review of biological artificial liver support systems. Artif. Organs 18:348-354; 1994.
9. Kawauchi, M.; Takeda, M.; Nakajima, J.; Matsumoto, J.; Furuse, A. Cardiac xenotransplantation from pig to Japanese monkey with splenectomy, tacrolims, filtration plasmapheresis, and nafamostat mesilate. Transplant. Proc. 26: 1076-1077; 1994.
10. Kobayashi, T.; Neethling, F. A.; Koren, E.; Taniguchi, S.; Ye, Y.; Niekrasz, M.; Takagi, H.; Hancock, W. W.; Cooper, D. K. C. In vitro and in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a nonhuman primate model. Transplant. Proc. 28:604; 1996.
11. Malchesky, P. S. Nonbiological liver support: Historical overview. Artif. Organs 18:342-347; 1994.
12. Manabe, T.; Hirano, T.; Imanishi, K.; Ando, K.; Yotsumoto, F.; Tobe, T. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis. Int. J. Pancreas 12:167-172; 1992.
13. Matsubara, S.; Okahe, K.; Ouchi, K.; Miyazaki, Y.; Yajima, Y.; Suzuki, H.; Otsuki, M.; Matsuno, S. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit. Care Med. 18:1331-1338; 1990.
14. Miyagawa, S.; Shirakura, R.; Matsumiya, G.; Fukushima, N.; Nakata, S.; Matsuda, H.; Matsumoto, M.; Kitamura, H.; Seya, T. Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT-175. Transplantation 55:709-713; 1993.
15. Nakamura, T.; Asano, O.; Ichihara, K.; Ichihara, A. Increased survival of rat hepatocytes in serum-free medium by inhibition of a trypsin-like protease associated with their plasma membranes. Exp. Cell Res. 154:81-91; 1984.
16. Neuzil, D. F.; Rozga, J.; Moscioni, A. D.; Ro, M. S.; Hakim, R.; Arnaout, W. S.; Demetriou, A. A. Use of a novel bioartificial liver in a patient with acute liver insufficiency. Surgery 113:340-343; 1993.
17. Niinobe, T.; Ueno, Y.; Hitomi, Y.; Fujii, S. Detection of intermediary Clr with complete active site, using a synthetic protease inhibitor. FEBS Lett. 172:159-162; 1984.
18. Ohta, K.; Tanaka, N.; Orita, K. Discordant liver xenograft transplantation. Transplant. Proc. 26:2435-2438; 1994.
19. Okada, S.; Sato, K.; Ichiki, K.; Tanokuchi, S.; Ishii, K.; Ota, Z.; Takeda, A. Does protease inhibitor inhibit complement activation caused by the immune complex associated with cell surface antibody? J. Int. Med. Res. 19:234-236; 1991.
20. Rozga, J.; Demetriou, A. A. Artificial liver. Evolution and future perspectives. ASAIO 41:831-837; 1995.
21. Rozga, J.; Podesta, L.; Le Page, E.; Morsani, F.; Moscioni, A. D.; Hoffman, A.; Sher, L.; Villamil, F.; Woolf, G.; McGrath, M.; Kong, L.; Rosen, H.; Lanman, T.; Vierling, J.; Makowka, L.; Demetriou, A. A. A bioartificial liver to treat severe acute liver failure. Ann. Surg. 5:538-546; 1994.
22. Seglen, P. O. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83; 1976.
23. Sussman, N. L.; Gislason, G. T.; Conlin, C. A.; Kelly, J. H. The hepatix extracorporeal liver assist device: Initial clinical experience. Artif. Organs 18:390-396; 1994.
24. Takahashi, M.; Ishikura, H.; Takahashi, C.; Nakajima, Y.; Matsushita, M.; Matsue, H.; Sato, K.; Sato, K.; Noto, H.; Taguchi, K. Immunologic considerations in the use of cultured porcine hepatocytes as a hybrid artificial liver. Antiporcine hepatocyte human serum. ASAIO 39:M242-246; 1993.
25. 2) and hydroxyl radical production by human polymorphonuclear leukocytes. Hepatogastroenterology 39: 59-61; 1992.
26. Tanaka, K.; Nakamura, T.; Ichihara, A. A unique trypsin-like protease associated with plasma membrane of rat liver. Purification and characterization. Biol. Chem. 261: 2610-2615; 1986.
27. Watanabe, F. D.; Mullon, C. J.; Hewitt, W. R.; Arkadopoulos, N.; Kahaku, E.; Eguchi, S.; Khalili, T.; Arnaout, W.; Shackleton, C. R.; Rozga, J.; Solomon, B.; Demetriou, A. A. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 225:484-494; 1997.